Dr. Reddy's Labs Files 6-K Report

Ticker: RDY · Form: 6-K · Filed: Sep 10, 2024 · CIK: 1135951

Sentiment: neutral

Topics: sec-filing, compliance, foreign-private-issuer

Related Tickers: RDY

TL;DR

Dr. Reddy's Labs filed a standard 6-K, confirming 20-F filings and providing corporate details.

AI Summary

Dr. Reddy's Laboratories Ltd. filed a Form 6-K on September 10, 2024, to report information as a foreign private issuer. The filing confirms the company's adherence to reporting requirements under the Securities Exchange Act of 1934, specifically noting it files annual reports under Form 20-F. The document provides standard corporate information and addresses for its principal executive office in Hyderabad, India.

Why It Matters

This filing is a routine update for investors and regulators, confirming Dr. Reddy's compliance with SEC reporting obligations as a foreign private issuer.

Risk Assessment

Risk Level: low — This is a routine administrative filing with no new material financial or operational information disclosed.

Key Players & Entities

FAQ

What is the purpose of a Form 6-K filing?

A Form 6-K filing is used by foreign private issuers to report information that they have made or are required to make public in their home country, or that they have submitted or are required to submit to their home country's stock exchange.

Which form does Dr. Reddy's Laboratories Ltd. use for its annual reports?

Dr. Reddy's Laboratories Ltd. files its annual reports under cover of Form 20-F.

What is the filing date of this Form 6-K?

This Form 6-K was filed on September 10, 2024.

Where is Dr. Reddy's Laboratories Ltd.'s principal executive office located?

The principal executive office of Dr. Reddy's Laboratories Ltd. is located at 8-2-337, Road No. 3, Banjara Hills, Hyderabad, Telangana 500 034, India.

Is Dr. Reddy's Laboratories Ltd. submitting this Form 6-K in paper format?

The filing does not indicate that the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1) or 101(b)(7).

Filing Stats: 402 words · 2 min read · ~1 pages · Grade level 16.8 · Accepted 2024-09-10 10:24:51

Filing Documents

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. DR. REDDY’S LABORATORIES LIMITED (Registrant) Date: September 10, 2024 By: /s/ K Randhir Singh Name: K Randhir Singh Title: Company Secretary 3

View Full Filing

View this 6-K filing on SEC EDGAR

View on Read The Filing